Data-mining analysis showed that eIF6 mRNA levels are dramatically associated with HCC progression and lethality in humans and that eIF6 could be a potential diagnostic and prognostic biomarker for HCC patients [93]. The gene discussed is EIF6; the disease is hepatocellular carcinoma.